Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Protective Effects of Fermented Oyster Extract against RANKL-Induced Osteoclastogenesis through Scavenging ROS Generation in RAW 264.7 Cells.

Jeong JW, Choi SH, Han MH, Kim GY, Park C, Hong SH, Lee BJ, Park EK, Kim SO, Leem SH, Jeon YJ, Choi YH.

Int J Mol Sci. 2019 Mar 21;20(6). pii: E1439. doi: 10.3390/ijms20061439.

2.

Sargassum serratifolium attenuates RANKL-induced osteoclast differentiation and oxidative stress through inhibition of NF-κB and activation of the Nrf2/HO-1 signaling pathway.

Kim HJ, Park C, Kim GY, Park EK, Jeon YJ, Kim S, Hwang HJ, Choi YH.

Biosci Trends. 2018;12(3):257-265. doi: 10.5582/bst.2018.01107.

4.

Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation.

Hyeon S, Lee H, Yang Y, Jeong W.

Free Radic Biol Med. 2013 Dec;65:789-799. doi: 10.1016/j.freeradbiomed.2013.08.005. Epub 2013 Aug 14.

PMID:
23954472
5.

The Effects of Aronia melanocarpa 'Viking' Extracts in Attenuating RANKL-Induced Osteoclastic Differentiation by Inhibiting ROS Generation and c-FOS/NFATc1 Signaling.

Ghosh M, Kim IS, Lee YM, Hong SM, Lee TH, Lim JH, Debnath T, Lim BO.

Molecules. 2018 Mar 8;23(3). pii: E615. doi: 10.3390/molecules23030615.

6.
7.

Receptor activator of nuclear factor-kappaB ligand-induced mouse osteoclast differentiation is associated with switching between NADPH oxidase homologues.

Sasaki H, Yamamoto H, Tominaga K, Masuda K, Kawai T, Teshima-Kondo S, Matsuno K, Yabe-Nishimura C, Rokutan K.

Free Radic Biol Med. 2009 Jul 15;47(2):189-99. doi: 10.1016/j.freeradbiomed.2009.04.025. Epub 2009 May 3.

PMID:
19409483
8.

CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.

Kim JY, Min JY, Baek JM, Ahn SJ, Jun HY, Yoon KH, Choi MK, Lee MS, Oh J.

Bone. 2015 Oct;79:242-51. doi: 10.1016/j.bone.2015.06.011. Epub 2015 Jun 21.

PMID:
26103094
9.

Xanthotoxin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis.

Dou C, Chen Y, Ding N, Li N, Jiang H, Zhao C, Kang F, Cao Z, Quan H, Luo F, Xu J, Dong S.

Osteoporos Int. 2016 Jul;27(7):2335-2344. doi: 10.1007/s00198-016-3496-8. Epub 2016 Jan 25.

PMID:
26809192
10.

Picrasidine I from Picrasma Quassioides Suppresses Osteoclastogenesis via Inhibition of RANKL Induced Signaling Pathways and Attenuation of ROS Production.

Kong L, Wang B, Yang X, Guo H, Zhang K, Zhu Z, Liu J, Hao D.

Cell Physiol Biochem. 2017;43(4):1425-1435. doi: 10.1159/000481874. Epub 2017 Oct 11.

11.

Acteoside suppresses RANKL-mediated osteoclastogenesis by inhibiting c-Fos induction and NF-κB pathway and attenuating ROS production.

Lee SY, Lee KS, Yi SH, Kook SH, Lee JC.

PLoS One. 2013 Dec 4;8(12):e80873. doi: 10.1371/journal.pone.0080873. eCollection 2013.

12.

Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.

Lee JH, Jin H, Shim HE, Kim HN, Ha H, Lee ZH.

Mol Pharmacol. 2010 Jan;77(1):17-25. doi: 10.1124/mol.109.057877. Epub 2009 Oct 14.

PMID:
19828731
13.

Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT.

Hong G, Zhou L, Shi X, He W, Wang H, Wei Q, Chen P, Qi L, Tickner J, Lin L, Xu J.

Int J Mol Sci. 2017 Jan 19;18(1). pii: E203. doi: 10.3390/ijms18010203.

14.

Agelasine D suppresses RANKL-induced osteoclastogenesis via down-regulation of c-Fos, NFATc1 and NF-κB.

Kang MR, Jo SA, Yoon YD, Park KH, Oh SJ, Yun J, Lee CW, Nam KH, Kim Y, Han SB, Yu J, Rho J, Kang JS.

Mar Drugs. 2014 Nov 24;12(11):5643-56. doi: 10.3390/md12115643.

15.

Inhibition of receptor activator of nuclear factor-κB ligand- or lipopolysaccharide-induced osteoclast formation by conophylline through downregulation of CREB.

Koide N, Kondo Y, Odkhuu E, Ulziisaikhan J, Ukaji T, Yokochi T, Umezawa K.

Immunol Lett. 2014 Sep;161(1):31-7. doi: 10.1016/j.imlet.2014.04.006. Epub 2014 May 2.

PMID:
24792671
16.

Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB/NFATc1 pathway in mouse bone marrow cells.

Kim JM, Lee JH, Lee GS, Noh EM, Song HK, Gu DR, Kim SC, Lee SH, Kwon KB, Lee YR.

BMC Complement Altern Med. 2017 Mar 23;17(1):164. doi: 10.1186/s12906-016-1550-x. Erratum in: BMC Complement Altern Med. 2017 Apr 28;17 (1):235.

17.

Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways.

Yuan FL, Xu RS, Jiang DL, He XL, Su Q, Jin C, Li X.

Bone. 2015 Jun;75:128-37. doi: 10.1016/j.bone.2015.02.017. Epub 2015 Feb 21.

PMID:
25708053
18.

Inhibition of osteoclast differentiation and bone resorption by sauchinone.

Han KY, Yang D, Chang EJ, Lee Y, Huang H, Sung SH, Lee ZH, Kim YC, Kim HH.

Biochem Pharmacol. 2007 Sep 15;74(6):911-23. Epub 2007 Jul 3.

PMID:
17662251
19.

The dectin 1 agonist curdlan regulates osteoclastogenesis by inhibiting nuclear factor of activated T cells cytoplasmic 1 (NFATc1) through Syk kinase.

Yamasaki T, Ariyoshi W, Okinaga T, Adachi Y, Hosokawa R, Mochizuki S, Sakurai K, Nishihara T.

J Biol Chem. 2014 Jul 4;289(27):19191-203. doi: 10.1074/jbc.M114.551416. Epub 2014 May 12.

20.

Carnosic acid attenuates RANKL-induced oxidative stress and osteoclastogenesis via induction of Nrf2 and suppression of NF-κB and MAPK signalling.

Thummuri D, Naidu VGM, Chaudhari P.

J Mol Med (Berl). 2017 Oct;95(10):1065-1076. doi: 10.1007/s00109-017-1553-1. Epub 2017 Jul 4.

PMID:
28674855

Supplemental Content

Support Center